TrialThe oncologist2016

A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.

Jianqing Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.